DBL Magnesium Sulfate

DBL Magnesium Sulfate

magnesium sulfate




Zuellig Pharma
Concise Prescribing Info
Mg sulfate heptahydrate
Acute hypomagnesaemia. Prevention of hypomagnesaemia in patients receiving TPN. Prevention & treatment of life-threatening seizures in treatment of pregnancy toxemias (preeclampsia & eclampsia).
Dosage/Direction for Use
Adult Total dose: Not to exceed 30-40 g daily. Mild hypomagnesaemia 1 g IM every 6 hr for 4 doses. Severe hypomagnesaemia 0.25 g/kg IM over 4 hr or 5 g slow IV infusion over 3 hr. TPN 0.5-3 g daily. Pregnancy toxemia Initially 4 g IV, followed by 4-5 g IM into each buttock or 1-2 g/hr infusion. May be followed by 4-5 g into alternate buttock every 4 hr. Infant TPN 0.25-1.25 g daily.
Heart block. Renal failure (CrCl <20 mL/min). Not to be used during pregnancy 2 hr prior to delivery.
Special Precautions
May precipitate acute myasthenic crisis. Periodically monitor serum Mg levels during therapy & urine output during 4 hr preceding dosing. Determine respiration rate prior to each dose. Test patellar reflex prior to administering repeated dose. Renal impairment. Not to be given during pregnancy 2 hr prior to delivery. Lactation.
Adverse Reactions
Hypermagnesaemia eg, nausea, vomiting, flushing, hypotension, muscle weakness & paralysis, blurred or double vision, CNS depression, loss of reflexes; hypocalcemia. Inj site irritation & pain.
Drug Interactions
Heart block w/ cardiac glycosides/digitalis. Enhanced CNS depressant effect. Excessive neuromuscular blockade w/ neuromuscular-blocking agents. Exaggerated hypotensive response w/ nifedipine. Precipitation w/ Ca salts. Incompatibiity w/ alkali carbonates & bicarbonates, soluble phosphates.
MIMS Class
ATC Classification
B05XA05 - magnesium sulfate ; Belongs to the class of electrolyte solutions used in I.V. solutions.
DBL Magnesium Sulfate inj 49.3 %
5 mL x 10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in